Help - Search - Members - Calendar
Full Version: Cirrhosis
Online Medical Forum > Library Database Of Journals Publications Researches Category > Library Database Of Journals Publications Researches > Medicine Category > Internal Medicine Forum > Medicine Topics > Cirrhosis
Pages: 1, 2, 3, 4, 5, 6, 7, 8
  1. Cirrhosis: Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two french clinical trials (0 replies)
  2. Cirrhosis: Enzyme may explain how hepatitis c infection causes fatty liver (0 replies)
  3. Cirrhosis: Regaining a healthy liver, one pound at a time (0 replies)
  4. Cirrhosis: Management of hepatitis b virus (0 replies)
  5. Cirrhosis: Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the gambia, west africa (0 replies)
  6. Cirrhosis: Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the gambia, west africa (0 replies)
  7. Cirrhosis: Addition of a total pancreatectomy and pancreas transplantation in a liver transplant recipient with intraductal papillary mucinous neoplasm of the pancreas (0 replies)
  8. Cirrhosis: Model consisting of ultrasonographic and simple blood indexes accurately identify compensated hepatitis b cirrhosis (0 replies)
  9. Cirrhosis: Pretreatment alanine transaminase level may not be the most important predictor of hepatitis b envelope antigen loss in the older patient (0 replies)
  10. Cirrhosis: Portopulmonary hypertension: survival and prognostic factors. (0 replies)
  11. Cirrhosis: Hepatitis c virus may need enzyme's help to cause liver disease (0 replies)
  12. Cirrhosis: Nitric oxide-independent activation of soluble guanylate cyclase by bay 60-2770 in experimental liver fibrosis. (0 replies)
  13. Cirrhosis: Cirrhosis: caring for patients with end-stage liver failure. (0 replies)
  14. Cirrhosis: M0002 progresses to phase iib trial following positive results in cirrhotic ascites (0 replies)
  15. Cirrhosis: Repeated administration of recombinant human serum albumin caused no serious allergic reactions in patients with liver cirrhosis: a multicenter clinical study (0 replies)
  16. Cirrhosis: Inflammatory pathways in liver homeostasis and liver injury (0 replies)
  17. Cirrhosis: Portal gas in a patient with alcoholic liver cirrhosis (0 replies)
  18. Cirrhosis: Primary biliary cirrhosis and osteoporosis: a case-control study (0 replies)
  19. Cirrhosis: European chmp recommends updating safety information on deferasinox (exjade) (0 replies)
  20. Cirrhosis: Genomics can advance the potential for probiotic cultures to improve liver and overall health. (0 replies)
  21. Cirrhosis: Advanced glycation end products (ages) and their involvement in liver disease. (0 replies)
  22. Cirrhosis: External validation of the platelet count/spleen diameter ratio for the diagnosis of esophageal varices in hepatitis c virus-related cirrhosis (0 replies)
  23. Cirrhosis: Additive inhibitory effect of experimentally induced hepatic cirrhosis by agonists of peroxisome proliferator activator receptor γ and retinoic acid receptor (0 replies)
  24. Cirrhosis: Alcohol and viral hepatitis: a mini-review. (0 replies)
  25. Cirrhosis: Frequent epigenetic inactivation of
    sfrp
    genes in hepatocellular carcinoma     (0 replies)
  26. Cirrhosis: Characteristic endoscopic features of portal hypertensive enteropathy (0 replies)
  27. Cirrhosis: Use of the model for end-stage liver disease (meld) score to predict 1-year survival of japanese patients with cirrhosis and to determine who will benefit from living donor liver transplantation (0 replies)
  28. Cirrhosis: [perioperative changes of coagulation functions in the local advanced liver cancer patients receiving liver transplantation.] (0 replies)
  29. Cirrhosis: A nested pcr method for the identification of hepatitis b virus genotype in paraffin blocks of formalin-fixed liver biopsies. (0 replies)
  30. Cirrhosis: Hepatitis b virus mutations associated with in situ expression of hepatitis b core antigen, viral load and prognosis in chronic hepatitis b patients. (0 replies)
  31. Cirrhosis: Impact of renal failure on survival of african patients with cirrhosis. (0 replies)
  32. Cirrhosis: Vascular endothelial growth factor levels in ascites between chemonaive and chemotreated patients. (0 replies)
  33. Cirrhosis: Diagnosis of liver cirrhosis by transit-time analysis at contrast-enhanced ultrasonography (0 replies)
  34. Cirrhosis: A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis. (0 replies)
  35. Cirrhosis: Production and characterization of monoclonal antibody specific for ns3 helicase of hepatitis c virus (0 replies)
  36. Cirrhosis: Autoimmunity: nkt cells linked to immune tolerance breakdown (0 replies)
  37. Cirrhosis: Chronic itching: causes and cures [scientific american mind] (0 replies)
  38. Cirrhosis: Probability and the patient state space (0 replies)
  39. Cirrhosis: Mr imaging findings in hepatic encephalopathy. (0 replies)
  40. Cirrhosis: Complications of cirrhosis. (0 replies)
  41. Cirrhosis: The hepatorenal syndrome. (0 replies)
  42. Cirrhosis: Hepatocellular carcinoma in cirrhotic liver disease functional computed tomography with perfusion imaging in the assessment of tumor vascularization. (0 replies)
  43. Cirrhosis: Primary myelofibrosis in a patient who developed primary biliary cirrhosis, autoimmune hemolytic anemia and fibrillary glomerulonephritis (0 replies)
  44. Cirrhosis: An integrated care pathway improves quality of life in primary biliary cirrhosis (0 replies)
  45. Cirrhosis: The impact of new data in the treatment of advanced hepatocellular carcinoma (0 replies)
  46. Cirrhosis: The pervading influence of alcoholic liver disease in hepatology (0 replies)
  47. Cirrhosis: Chronic liver disease--an increasing problem: a study of hospital admission and mortality rates in england, 1979-2005, with particular reference to alcoholic liver disease (0 replies)
  48. Cirrhosis: Comparative hepatitis (0 replies)
  49. Cirrhosis: Sepsis a leading cause of death in cirrhosis (0 replies)
  50. Cirrhosis: Transjugular intrahepatic porto-caval shunt (tips) in treatment of portal hypertension in liver transplant recipiens. (0 replies)
  51. Cirrhosis: Morphological features and differential diagnosis of hepatitis c recurrence after liver transplantation - literature review and results of single transplantation center. (0 replies)
  52. Cirrhosis: Pegylated interferon alpha-2b plus ribavirin for naive patients with hcv-related cirrhosis. (0 replies)
  53. Cirrhosis: Irbesartan added to propranolol may improve cirrhosis therapy (0 replies)
  54. Cirrhosis: Peripheral blood monocytes from the decompensated liver cirrhosis could migrate into nude mouse liver with human hepatocyte-markers expression. (0 replies)
  55. Cirrhosis: Review article: current antiviral therapy of chronic hepatitis b (0 replies)
  56. Cirrhosis: Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival (0 replies)
  57. Cirrhosis: Dynamic ct of portal hypertensive gastropathy: significance of transient gastric perfusion defect sign. (0 replies)
  58. Cirrhosis: [hepatobiliary imaging] nonhypervascular hypoattenuating nodules depicted on either portal or equilibrium phase multiphasic ct images in the cirrhotic liver (0 replies)
  59. Cirrhosis: Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis (0 replies)
  60. Cirrhosis: Hypercalcemia of primary hyperparathyroidism was treated by cinacalcet in a patient with liver cirrhosis (0 replies)
  61. Cirrhosis: Blood pressure changes with acupuncture comparable to those with ace inhibitor monotherapy (0 replies)
  62. Cirrhosis: Late-onset autoimmunity: the paradigm of primary biliary cirrhosis -- a mini-review (0 replies)
  63. Cirrhosis: Shewanella soft tissue infection: case report and literature review. (0 replies)
  64. Cirrhosis: [hepatology] uncoupling protein-2 (ucp2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (nash) liver to ischaemia-reperfusion injury (0 replies)
  65. Cirrhosis: [postscript] response to "meld score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation" (0 replies)
  66. Cirrhosis: Neutropenic enterocolitis: an unusual complication of hcv combination therapy with peg-ifn and ribavirin. (0 replies)
  67. Cirrhosis: Successful endoscopic sclerotherapy for bleeding gastric varices with combined cyanoacrylate and aethoxysklerol. (0 replies)
  68. Cirrhosis: Preventive effect of qianggan-rongxian decoction on rat liver fibrosis. (0 replies)
  69. Cirrhosis: Topiramate has physical and psychosocial benefits in heavy drinkers (0 replies)
  70. Cirrhosis: Hepatitis e virus-related cirrhosis in kidney-and kidney–pancreas-transplant recipients (0 replies)
  71. Cirrhosis: Effect of alcohol, cigarette smoking, and diabetes on occurrence of hepatocellular carcinoma in patients with transfusion-acquired hepatitis c virus infection who develop cirrhosis. (0 replies)
  72. Cirrhosis: Uncoupling of sympathetic nervous system and hypothalamic-pituitary-adrenal axis in cirrhosis (0 replies)
  73. Cirrhosis: Successful rescue therapy with only 4 weeks ribavirin monotherapy in end-stage cirrhosis due to genotype 2 chronic hepatitis c (0 replies)
  74. Cirrhosis: Altered mesenteric venous capacitance and volume pooling in cirrhotic rats are mediated by nitric oxide. (0 replies)
  75. Cirrhosis: Topiramate has physical and psychosocial benefits in heavy drinkers (0 replies)
  76. Cirrhosis: Cpg island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma (0 replies)
  77. Cirrhosis: Enhanced actions of insulin-like growth factor-i and interferon-α co-administration in experimental cirrhosis (0 replies)
  78. Cirrhosis: New diagnostic method for liver fibrosis and cirrhosis (0 replies)
  79. Cirrhosis: Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis (0 replies)
  80. Cirrhosis: Differential vascular endothelial growth factor a protein expression between small hepatocellular carcinoma and cirrhosis correlates with serum vascular endothelial growth factor a and α-fetoprotein (0 replies)
  81. Cirrhosis: Transforming growth factor beta1 gene variants increase transcription and are associated with liver cirrhosis in chinese. (0 replies)
  82. Cirrhosis: Breaking tolerance to the natural human liver autoantigen cytochrome p450 2d6 by virus infection (0 replies)
  83. Cirrhosis: Study of the association between polymorphisms of the
    col1a1
    gene and hbv-related liver cirrhosis in chinese patients     (0 replies)
  84. Cirrhosis: Color doppler velocity profile and contrast-enhanced ultrasonography in assessment of liver cirrhosis. (0 replies)
  85. Cirrhosis: Autoimmune liver diseases. (0 replies)
  86. Cirrhosis: Clinical features and management of autoimmune hepatitis. (0 replies)
  87. Cirrhosis: Etiopathogenesis of primary biliary cirrhosis. (0 replies)
  88. Cirrhosis: Clinical features and management of primary sclerosing cholangitis. (0 replies)
  89. Cirrhosis: Overlap syndromes among autoimmune liver diseases. (0 replies)
  90. Cirrhosis: Autoimmune liver serology: current diagnostic and clinical challenges. (0 replies)
  91. Cirrhosis: Hepatic encephalopathy in patients with liver cirrhosis: is there a role of malnutrition? (0 replies)
  92. Cirrhosis: Diabetes boosts liver cancer risk in hepatitis, cirrhosis cases (0 replies)
  93. Cirrhosis: Diabetes boosts liver cancer risk in hepatitis, cirrhosis cases (0 replies)
  94. Cirrhosis: Diabetes boosts liver cancer risk in hepatitis, cirrhosis cases (0 replies)
  95. Cirrhosis: Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence (0 replies)
  96. Cirrhosis: Comprehensive analysis of adamts13 in patients with liver cirrhosis. (0 replies)
  97. Cirrhosis: Clinical insights from observations on adamts13 deficiency in liver cirrhosis. (0 replies)
  98. Cirrhosis: Current and emerging surrogate markers of hepatic fibrosis in primary biliary cirrhosis (0 replies)
  99. Cirrhosis: Off-pump coronary artery bypass grafting in a patient with liver cirrhosis (0 replies)
  100. Cirrhosis: Liver resection: prolonged inflow occlusion in human cirrhotic livers (0 replies)
  101. Cirrhosis: Diabetes may increase risk for hepatocellular carcinoma in patients with hepatitis c (0 replies)
  102. Cirrhosis: Circulating and hepatic fas expression in hcv-induced chronic liver disease and hepatocellular carcinoma (0 replies)
  103. Cirrhosis: Colorectal surgery in cirrhotic patients: assessment of operative morbidity and mortality (0 replies)
  104. Cirrhosis: Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of bclc, clip and gretch staging systems (0 replies)
  105. Cirrhosis: Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes. (0 replies)
  106. Cirrhosis: Relationship between hospital volume and outcomes of esophageal variceal bleeding in the united states. (0 replies)
  107. Cirrhosis: Viral hepatitis b: established and emerging therapies. (0 replies)
  108. Cirrhosis: Cryptic hepatitis b virus replication during prednisone therapy in type b chronic active hepatitis (0 replies)
  109. Cirrhosis: Iga antibodies to dietary antigens in liver cirrhosis (0 replies)
  110. Cirrhosis: Strategies for resection using portal vein embolization: hepatocellular carcinoma and hilar cholangiocarcinoma (0 replies)
  111. Cirrhosis: Sequential transcatheter arterial chemoembolization and portal vein embolization for hepatocellular carcinoma: the university of tokyo experience (0 replies)
  112. Cirrhosis: Sequential arterial and portal vein embolization in patients with cirrhosis and hepatocellular carcinoma: the hospital beaujon experience (0 replies)
  113. Cirrhosis: Hemobilia and cystic artery stump pseudoaneurysm associated with liver abscess after a laparoscopic cholecystectomy: report of a case (0 replies)
  114. Cirrhosis: Characterization of virus-specific t-cell immunity in liver allograft recipients with hcv-induced cirrhosis (0 replies)
  115. Cirrhosis: In brief (0 replies)
  116. Cirrhosis: Interstitial lung disease and sjögren’s syndrome in primary biliary cirrhosis: a causal or casual association? (0 replies)
  117. Cirrhosis: Lopinavir/ritonavir pharmacokinetics in hiv/hcv-coinfected patients with or without cirrhosis. (0 replies)
  118. Cirrhosis: Orphan therapeutics announces initiation of rolling nda submission for lucassin(r) (terlipressin) for the treatment of hepatorenal syndrome type 1 (0 replies)
  119. Cirrhosis: Approach to patients with hbv and hcv coinfection (0 replies)
  120. Cirrhosis: Critical analysis of the immune tolerance phase of chronic hbv infection: natural history and diagnosis (0 replies)
  121. Cirrhosis: Does hcv antiviral therapy decrease the risk of hepatocellular carcinoma? (0 replies)
  122. Cirrhosis: The chemical pathway to primary biliary cirrhosis (0 replies)
  123. Cirrhosis: Diabetes doubles liver cancer risk for patients with advanced hepatitis c (0 replies)
  124. Cirrhosis: Tips, cirrhosis cirrhose - color ultrasound (0 replies)
  125. Cirrhosis: Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two french clinical trials (0 replies)
  126. Cirrhosis: Necrotising fasciitis caused by vibrio vulnificus in a man with cirrhosis. (0 replies)
  127. Cirrhosis: Antimitochondrial antibody-negative primary biliary cirrhosis. (0 replies)
  128. Cirrhosis: Long-term remission by cyclosporine in a patient with eosinophilic fasciitis associated with primary biliary cirrhosis (0 replies)
  129. Cirrhosis: Liver cirrhosis, other liver diseases, and risk of hospitalisation for intracerebral haemorrhage: a danish population-based case-control study (0 replies)
  130. Cirrhosis: The spectrum of hepatic functional impairment in compensated chronic hepatitis c: results from the hepatitis c anti-viral long-term treatment against cirrhosis trial (0 replies)
  131. Cirrhosis: Liver fibrogenesis and the role of tsp-1 (0 replies)
  132. Cirrhosis: Cost saving for esophageal varices (0 replies)
  133. Cirrhosis: Pathogenesis and clinical significance of liver injury in celiac disease (0 replies)
  134. Cirrhosis: Characteristics of hepatocellular carcinoma in india: a retrospective analysis of 191 cases (0 replies)
  135. Cirrhosis: Clinical and serological profile of primary biliary cirrhosis in young and elderly patients (0 replies)
  136. Cirrhosis: Antiviral treatment in patients with hepatitis c virus-related cirrhosis awaiting liver transplantation (0 replies)
  137. Cirrhosis: Time for an active antiviral therapy for hepatitis b: an update on the management of hepatitis b virus infection (0 replies)
  138. Cirrhosis: Striving toward better diagnosis and treatment of liver diseases (0 replies)
  139. Cirrhosis: A case-control study of the relationship between hepatitis b virus dna level and risk of hepatocellular carcinoma in qidong, china. (0 replies)
  140. Cirrhosis: Liver disease: stem cell use and news in cirrhosis and hepatitis (0 replies)
  141. Cirrhosis: Subpopulations of t lymphocytes in patients with chronic active liver disease (0 replies)
  142. Cirrhosis: Liver diseases: striving toward better diagnosis and treatment (0 replies)
  143. Cirrhosis: Outcome predictors and new score of critically ill cirrhotic patients with acute renal failure (0 replies)
  144. Cirrhosis: Treatment of chronic hepatitis b: recommendations from an italian workshop. (0 replies)
  145. Cirrhosis: Bacteroides fragilis arch mycotic aneurysm
    - case report with review     (0 replies)
  146. Cirrhosis: Common bacteria activating natural killer t cells may cause autoimmune liver disease (0 replies)
  147. Cirrhosis: Researchers close in on possible cause of autoimmune liver disease (0 replies)
  148. Cirrhosis: Management of hepatitis b virus co-infection on and off antiretroviral therapy (0 replies)
  149. Cirrhosis: Alcohol dehydrogenase (adh) isoenzymes and aldehyde dehydrogenase (aldh) activity in the sera of patients with liver cancer (0 replies)
  150. Cirrhosis: Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease (0 replies)
This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here.
Invision Power Board © 2001-2009 Invision Power Services, Inc.